Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiovascular Diseases 3Metabolic Syndrome 2Breast Neoplasms 2Stomach Neoplasms 1Sarcoidosis 1Obesity 1Non-alcoholic Fatty Liver Disease 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Cirrhosis 1Hodgkin Disease 1Colorectal Neoplasms 1Cardiotoxicity 1

Interventions

Doxorubicin 11Razoxane 5Dexrazoxane 5Electrocardiography 4Echocardiography 4Cyclophosphamide 4Vincristine 3Trastuzumab 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Exercise 3Etoposide 3Carvedilol 3Radiotherapy 2Prednisone 2Methotrexate 2Magnetic Resonance Spectroscopy 2Bleomycin 2salicylhydroxamic acid 1oblimersen 1hydrocortisone hemisuccinate 1dapagliflozin 1Vascular Stiffness 1VAP-cyclo protocol 1Tablets 1Silymarin 1Reverse Transcriptase Polymerase Chain Reaction 1Resistance Training 1Pulse Wave Analysis 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cardiotoxicity × Blood Pressure × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡